title: Hypolipidemic effect of Pleurotus eryngii extract in fat-loaded mice.
abstract: Pleurotus eryngii water extract (PEE), which showed the most significant inhibitory activity against pancreatic lipase in vitro among eight edible mushrooms, was investigated to determine the mechanism of its anti-lipase activity in vitro and its hypolipidemic effect in fat-loaded mice. The inhibitory effects of mushroom extracts on pancreatic lipase activity were examined using 4-methylumbelliferyl oleate (4-MUO) or trioleoylglycerol emulsified with lecithin, gum arabic or Triton X-100 as a substrate. For in vivo experiments, blood samples were taken after oral administration of corn oil and [(3)H]trioleoylglycerol with or without PEE to food-deprived mice. PEE inhibited hydrolysis of 4-MUO and trioleoylglycerol emulsified with lecithin or Triton X-100, but not that of trioleoylglycerol emulsified with gum arabic. PEE suppressed the elevations of plasma and chylomicron triacylglycerol levels after oral administration of corn oil, but had no effect on lipoprotein lipase activity. [(3)H]Trioleoylglycerol absorption was also decreased by administration of PEE. The results of in vitro studies suggest that PEE may prevent interactions between lipid emulsions and pancreatic lipase. The hypolipidemic effect of PEE in fat-loaded mice may be due to low absorption of fat caused by the inhibition of pancreatic lipase.
authors.affiliation: Mushroom Research Laboratory, Hokuto Corporation, Nagano, Japan.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Mizutani
authors.forename: Satoshi
authors.initials: S
authors.lastname: Inatomi
authors.forename: Akihiro
authors.initials: A
authors.lastname: Inazu
authors.forename: Ei
authors.initials: E
authors.lastname: Kawahara
mesh_terms: D000818:Animals; D001688:Biological Products / Q000494:pharmacology* / Q000627:therapeutic use; D002914:Chylomicrons; D003314:Corn Oil / Q000008:administration & dosage; D004041:Dietary Fats / Q000378:metabolism*; D004195:Disease Models, Animal; D004655:Emulsions; D005508:Food Deprivation; D006868:Hydrolysis; D006923:Hymecromone / Q000031:analogs & derivatives / Q000378:metabolism; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008049:Lipase / Q000037:antagonists & inhibitors*; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009765:Obesity / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology* / Q000627:therapeutic use; D020076:Pleurotus; D014280:Triglycerides / Q000097:blood; D014304:Triolein / Q000378:metabolism
chemical_list: D001688:Biological Products; D002914:Chylomicrons; D004041:Dietary Fats; D004655:Emulsions; D000960:Hypolipidemic Agents; D010936:Plant Extracts; D014280:Triglycerides; D014304:Triolein; C023520:4-methylumbelliferyl oleate; D006923:Hymecromone; D003314:Corn Oil; D008049:Lipase; D008071:Lipoprotein Lipase